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A B S T R A C T
A series of new 6-methoxyquinoline-3-carbonitrile derivatives were synthesized using a variety
of synthetic routes. The newly synthesized compounds have been characterized by IR, 1H
NMR, and mass spectral data followed by elemental analysis. All of the synthesized com-
pounds were evaluated for their in-vitro antimicrobial activity against Streptococcus pneumonia
and Bacillus subtilis as examples for Gram-positive bacteria, Pseudomonas aeruginosa and Es-
cherichia coli as examples for Gram-negative bacteria, and Aspergillus fumigatus, Syncephalastrum
racemosum, Geotriucum candidum and Candida albicans as representative examples of fungi.
The majority of tested compounds showed moderate activities against wide range of se-
lected organisms. Among the tested compounds, the ester derivative 7b and the thioether
derivative 9c showed the highest antimicrobial activity against gram-positive strains
while the highest activity against gram-negative strains was observed in case of 7b, 7d
and 9b while compound 7e found more active than Amphotericin B against three fungal
species.
© 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of Beni-Suef Uni-
versity. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
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1. Introduction
The discovery and development of antimicrobial agents that
has met with enormous success over the past 50 years pro-
vided many classes of natural products and synthetic
compounds. Among them, quinoline derivatives are still an
important class of therapeutically useful antibacterial drugs
(Agui et al., 1977; Kharb and Kaur, 2013). Additionally, infec-
tions caused by microbes thus far not considered as pathogens
in the normal host have become a challenging problem in the
past decade, due to an increase in the number of elderly pa-
tients, new medical techniques such as implantable devices,
and patients suffering from severe immunosuppression that
necessitates requiring continuous search into novel classes of
antibacterial agents (Bonatti et al., 2003). At least in the United
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States, deaths caused by a single multi-resistant species, MRSA,
might be more than those caused by AIDS (Anibal et al., 2010).
The aim of this work is to develop a new set of antibacterial
agents belonging to quinoline scaffold that cannot be recog-
nized by bacterial resistant machineries (Fig. 1). Structurally
related quinoline analogues have been well-known a long time
ago, but cross-resistance has not been reported yet. As previ-
ously mentioned some heterocyclic compounds containing
2-chloroquinolne-3-carbaldehyde moiety have been docu-
mented as antimicrobial agents (Burckhalter et al., 1961; Dow
et al., 2004). Some of the recently modified quinolines (Fig. 2)
include Bedaquiline, which has shown extraordinary activity
against both drug susceptible and drug-resistant strains ofMy-
cobacterium tuberculosis (Diacon et al., 2009). Laquinimod is a
quinoline derivative currently under investigation for oral treat-
ment of multiple sclerosis (MS) (Haggiag et al., 2013). Glaxo-
SmithKline 299423 is an investigational quinoline derivative
that has shown potent activity against antibiotic-resistant
strains of bacteria such as Staphylococus aureus, including methi-
cillin resistance strains (MRSA) and gram-negative bacteria like
Escherichia coli (Bax et al., 2010). In this study, Glaxo-SmithKline
299423 (3) was used as lead compound with modification at
position 2 by introducing different functional groups like amide,
ester and thioether aiming to obtain active antimicrobial com-
pounds. Depending on the above-mentioned facts, and for
further investigation of novel antimicrobial agents, the global
aim of the current work was designed to synthesize some new
derivatives of 6-methoxyquinoline-3-carbonitriles, which
showed promising antimicrobial activity.
2. Experimentals
2.1. General
All melting points were determined by open capillary using
Gallenkampmelting point apparatus and are uncorrected.The
IR spectra (in KBr discs) were recorded on potassium bromide
discs on a Pye Unicam SP 3300 spectrophotometer. 1H NMR
spectra were recorded on Gemini 300 MHz usingTMS as an in-
ternal standard. All chemical shifts are reported in ppm
downfield fromTMS.Mass spectrawere recorded on a Shimadzu
GCMS-QP 1000 EX mass spectrometer operating at 70 eV. El-
emental analyses were carried out at the Regional Center for
Mycology and Biotechnology,Al-Azhar University, Cairo, Egypt.
Progress of the reactionswasmonitored byTLC sheets precoated
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Fig. 1 – Graphical abstract of the newly synthesized 6-methoxyquinoline-3-carbonitrile derivatives.
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Fig. 2 – Chemical structures of some potent antimicrobial quinoline derivatives.
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with UV fluorescent silica gel Merck 60 F254 plates and were
visualized using UV lamp and n-hexane:ethyl acetate 9:1 as
mobile phase. Startingmaterials were purchased fromAldrich
Chemical Company andusedwithout further purification.Com-
pound 4 was prepared according to reported procedure
(Rajakumar and Raja, 2015; Venkatesan and Sumathi, 2010) by
applyingVilsmeier–Haack reactionof phosphorus oxytrichloride,
N,N-dimethylformamidewithN-(4-anisyl)acetamide. 2-Chloro-
6-methoxyquinoline-3-carbonitrile (5) was obtained following
literature procedures (Augustine et al., 2009; Upadhya et al.,
2009). 2-Mercapto-6-methoxyquinoline-3-carbonitrile (6) was
preparedby reacting 2-chloro-6-methoxyquinoline-3-carbonitrile
5 with thiourea in dry ethanol (Nandeshwarappa et al., 2006;
Prakash et al., 2009). For synthesis of the new derivatives,
Scheme 1 was adopted.
2.2. General procedure for synthesis of 2-(3-Cyano-6-
methoxyquinolin-2-ylthio)-N-(aryl)acetamides 7a–f
A mixture of compound 6 (2.16 g, 10 mmol) and the appropri-
ate chloroacetanilide (10 mmol) in DMF (20 mL) containing
anhydrous sodium acetate (1.23 g, 15 mmol) was heated over
water bath for 3 hours.The reaction mixture was then cooled,
poured into ice-cooled water (200 mL), and stirred well for
30 min. The solid thus separated was filtered, washed with
water, dried, and crystallized from ethanol to obtain com-
pounds 7a–f as white needles.
2.2.1. 2-(3-Cyano-6-methoxyquinolin-2-ylthio)-N-
(2,6-dichlorophenyl)acetamide (7a)
Yield (3.55 g, 85%); mp 250–251 °C; IR (KBr) υmax/cm−1; 3288 (NH),
3032 (C-H aromatic), 2957 (CH aliphatic), 2220 (C≡N) and 1655
(C=O); 1H NMR (DMSO): 10.29 (s, 1H, NH, D2O exchangeable),
9.0 (s, 1H, Quinoline H4), 7.7 (d, 1H, J = 9 Hz, Quinoline H8), 7.6
(d, 2H, J = 6 Hz, phenyl H3, H5), 7.5 (d, 1H, J = 9 Hz, Quinoline
H7), 7.4 (t, 1H, J = 6 Hz, phenyl H4) 7.3 (s, 1H, Quinoline H5), 4.36
(s, 2H, S-CH2), and 3.95 (s, 3H, OCH3); MS (m/z, %); 418 (M, 1.94%),
257 (M – NHC6H3Cl2, 100%) and 229 (M – NHC6H3Cl2 – CN, 64.05%);
Anal. Calcd for C19H13Cl2N3O2S, (418): C, 65.61; H, 5.82; N, 4.28%.
Found: C, 65.64; H, 5.87; N, 4.32%.
2.2.2. 2-(3-cyano-6-methoxyquinolin-2-ylthio)-N-m-
tolylacetamide (7b)
Yield (3.09 g, 85%); mp 222–223 °C; IR (KBr) υmax/cm−1; 3300 (NH),
3031 (CH aromatic), 2900 (CH aliphatic), 2221 (C≡N), 1665 (C=O);
1H NMR (DMSO): 10.42 (s, 1H, NH, D2O exchangeable), 8.87
(s, 1H, quinoline H4), 7.8 (d, 1H, J = 9.6 Hz, quinoline H8), 7.6 (d,
1H, J = 9.6 Hz, Quinoline H7), 7.5 (s, 1H, phenyl H2), 7.4 (s, 1H,
quinoline H5), 7.3 (d, 1H, J = 7.8 Hz, phenyl H6), 7.2 (t, 1H, J = 15 Hz,
phenyl H5), 6.8 (d, 1H, J = 6 Hz, phenyl H4), 4.2 (s, 2H, S-CH2),
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Scheme 1 – Synthetic protocol for compounds 7a–f, 8a–c and 8a–d.
340 b en i - s u e f un i v e r s i t y j o u rna l o f b a s i c and a p p l i e d s c i e n c e s 4 ( 2 0 1 5 ) 3 3 8 – 3 4 5
3.95 (s, 3H, OCH3), 2.6 (s, 3H, CH3); MS (m/z, %); 363 (M, 9.34%),
257 (M – NHC6H4CH3, 100%), 229 (M – NHC6H4CH3 – CN, 75.70%)
and 107 (NHC6H4CH3, 44.60%); Anal. Calcd for C20H17N3O2S, (363):
C, 66.10; H, 4.71; N, 11.56%. Found: C, 66.21; H, 4.69; N, 11.61%.
2.2.3. 2-(3-Cyano-6-methoxyquinolin-2-ylthio)-N-
(2-chlorophenyl)acetamide (7c)
Yield (3.07, 80%); mp 239–240 °C; IR (KBr) υmax/cm−1; 3295 (NH),
3080 (CH aromatic), 2900 (CH aliphatic), 2222 (C≡N), 1675 (C=O);
1H NMR (DMSO): 10.1 (s, 1H, NH, D2O exchangeable), 9.0 (s, 1H,
Quinoline H4), 7.8 (d, 1H, J = 9 Hz, Quinoline H8), 7.6 (d, 1H,
J = 9 Hz, Quinoline H7), 7.5 (d, 2H, J = 18 Hz, phenyl H3, H6), 6.8
(t, 2H, J = 18, phenyl H4, H5), 7.4 (s, 1H, Quinoline H5), 4.35 (s,
2H, S-CH2), 3.95 (s, 3H, OCH3); MS (m/z, %); 383 (M, 1.42%), 257
(M – NHC6H4Cl, 100%) and 229 (M – NHC6H4Cl – CN, 73.51%); Anal.
Calcd for C19H14ClN3O2S, (383): C, 59.45; H, 3.68; N, 10.95%. Found:
C, 59.62; H, 3.65; N, 11.21%.
2.2.4. 2-(3-Cyano-6-methoxyquinolin-2-ylthio)-N-
(4-chlorophenyl)acetamide (7d)
Yield (3.07, 80%); mp 239–240 °C; IR (KBr) υmax/cm−1; 3296 (NH),
3082 (CH aromatic), 2905 (CH aliphatic), 2221 (C≡N), 1674 (C=O);
1H NMR (DMSO): 10.1 (s, 1H, N-H, D2O exchangeable), 9.0 (s, 1H,
Quinoline H4), 7.8 (d, 1H, J = 9 Hz, Quinoline H8), 7.6 (d, 1H,
J = 9 Hz, Quinoline H7), 7.4 (s, 1H, Quinoline H5), 6.8–7.0 (2d, 4H,
J = 18 Hz, Phenyl H 2, 3, 5 and 6), 4.35 (s, 2H, S-CH2) and 3.95
(s, 3H, OCH3); MS (m/z, %); 383 (M, 0.87%), 257 (M – NHC6H4Cl,
100%) and 229 (M – NHC6H4Cl – CN, 90.46%); Anal. Calcd for
C19H14ClN3O2S, (383): C, 59.45; H, 3.68; N, 10.95%. Found: C, 59.62;
H, 3.65; N, 11.21%.
2.2.5. 2-(3-Cyano-6-methoxyquinolin-2-ylthio)-N-
(4-methoxyphenyl) acetamide (7e)
Yield (3.22 g, 85%); mp 230–231 °C; IR (KBr) υmax/cm−1; 3261 (NH),
3071 (CH aromatic), 2910 (CH aliphatic), 2225 (C≡N), 1666 (C=O);
1H NMR (DMSO): 10.29 (s, 1H, NH, D2O exchangeable), 9.0 (s, 1H,
Quinoline H4), 7.8 (d, 1H, J = 9 Hz, Quinoline H8), 7.6 (d, 1H,
J = 9 Hz, Quinoline H7), 7.5 (d, 2H, J = 18 Hz, phenyl H2, 6), 7.4
(s, 1H, Quinoline H5), 6.8 (d, 2H, J = 18, phenyl H3, 5), 4.2 (s, 2H,
SCH2), 3.95 (s, 3H, Quinoline OCH3) and 3.7 (s, 3H, phenyl OCH3);
MS (m/z, %); 379 (M, 2.90%), 257 (M – NHC6H4OCH3, 29.90%) and
229 (M – NHC6H4OCH3 – CN, 100%); Anal. Calcd for C20H17N3O3S,
(379): C, 63.31; H, 4.52; N, 11.07 %. Found: C, 63.62; H, 4.6; N,
11.35%.
2.2.6. 2-(3-Cyano-6-methoxyquinolin-2-ylthio)-N-
(2,4,6-tribromophenyl)acetamide (7f)
Yield (4.37 g, 75%); mp 270–271 °C; IR (KBr) υmax/cm−1; 3321 (NH),
3026 (CH aromatic), 2925 (CH aliphatic), 2222 (C≡N), 1670 (C=O);
1H NMR (DMSO): 10.29 (s, 1H, NH, D2O exchangeable), 9.0 (s, 1H,
quinoline-H4), 7.8 (d, 1H, J = 9 Hz, quinoline H8), 7.7 (s, 2H,
phenyl-H3, H5), 7.6 (d, 1H, J = 9 Hz, quinoline H7), 7.4 (s, 1H,
quinoline H5), 4.3 (s, 2H, S-CH2) and 3.95 (s, 3H, OCH3); MS (m/
z, %); 418 (M, 1.94%), 257 (M – NHC6H2Br3, 63.33%) and 230 (M
– CONHC6H2Br3, 100%); Anal. Calcd for C19H12Br3N3O2S, (583): C,
38.94; H, 2.06; N, 7.17%. Found: C, 39.29; H, 2.03; N, 7.29%.
2.3. General procedure for synthesis of alkyl-2-
(3-cyano-6-methoxyquinolin-2-ylthio)alkanoates 8a–c
A mixture of 6 (2.16 g, 10 mmol) and the appropriate alkyl
chloroacetate or chloropropionate (10 mmol) in DMF (20 ml)
containing anhydrous sodium acetate (1.23 g, 15 mmol) was
heated on a water-bath with continuous stirring for 6 h, the
solid so obtainedwasfiltered,dried and crystallized fromethanol
to afford the corresponding ester derivatives 8a–c as white
needles.
2.3.1. Ethyl 2-(3-cyano-6-methoxyquinolin-2-ylthio)acetate
(8a)
Yield (2.14 g, 80%); mp 135–136 °C; IR (KBr) υmax/cm−1; 3060 (CH
aromatic), 2970 (CH aliphatic), 2222 (C≡N) and 1719 (C=O); 1H
NMR (DMSO): 9.0 (s, 1H, Quinoline H4), 7.9 (d, 1H, J = 9 Hz, quino-
line H8), 7.5 (d, 1H, J = 9 Hz, quinoline H7), 7.4 (s, 1H, quinoline
H-5), 4.6 (s, 2H, S-CH2), 4.3 (q, 2H, J = 21 Hz, O-CH2), 3.9 (s, 3H,
O-CH3) and 1.3 (t, 3H, J = 15 Hz, CH2-CH3); MS (m/z, %); 302
(C15H14N2O3S, 9%, M), 257 (M – OC2H5, 5.3%), 229 (M – OC2H5 –
CN, 100%), 214 (M – CH2COOC2H5, 5.4%); Anal. Calcd for
C15H14N2O3S, (302): C, 59.59; H, 4.67; N, 9.27%. Found: C, 59.12;
H, 4.29; N, 9.70%.
2.3.2. Methyl 2-(3-cyano-6-methoxyquinolin-2-ylthio)acetate
(8b)
Yield (2.38 g, 85%); mp 141–142 °C; IR (KBr) υmax/cm−1; 3069 (CH
aromatic), 2948 (CH aliphatic), 2220 (C≡N) and 1731 (C=O); 1H
NMR (DMSO): 9.0 (s, 1H, quinoline H4), 7.9 (d, 1H, J = 9 Hz, quino-
line H8), 7.5 (d, 1H, J = 9 Hz, quinoline H7), 7.4 (s, 1H, quinoline
H5), 4.2 (s, 2H, SCH2), 3.9 (s, 3H, O-CH3), 3.6 (s, 3H, COO-CH3);
MS (m/z, %); 288 (M, 100%), 257 (M – OCH3, 20%), 229 (M – OCH3
– CN, 99%); Anal. Calcd for C14H12N2O3S, (288): C, 58.32; H, 4.20;
N, 9.72%. Found: C, 58.43; H, 4.27; N, 9.88%.
2.3.3. Ethyl 2-(3-cyano-6-methoxyquinolin-2-
ylthio)propanoate (8c)
Yield (2.68 g, 85%); mp 160–161 °C; IR (KBr) υmax/cm−1; 3052 (CH
aromatic), 2926 (CH aliphatic), 2222 (C≡N) and 1735 (C=O); 1H
NMR (DMSO): 9.0 (s, 1H, quinoline H4), 7.9 (d, 1H, J = 9 Hz, quino-
line H8), 7.5 (d, 1H, J = 9 Hz, quinoline H7), 7.4 (s, 1H, quinoline
H5), 4.6 (q, 1H, J = 12 Hz, S-CH), 4.1 (q, 2H, J = 10.8 Hz, OCH2), 3.9
(s, 3H, OCH3), 1.6 (d, 3H, J = 12 Hz, SCHCH3), 1.1 (t, 3H, J = 15 Hz,
CH2CH3); MS (m/z, %); 316 (M, 100%), 257 (M – OCH3, 20%), 229
(M – OCH3 – CN, 99%); Anal. Calcd for C16H16N2O3S, (316): C, 60.74;
H, 5.10; N, 8.85%. Found: C, 60.83; H, 5.02; N, 8.97%.
2.4. General procedure for synthesis of 6-methoxy-2-
(alkyl or aralkylthio)quinoline-3-carbonitrile 9a–d
Into a suspension of 2-mercapto-6-methoxyquinoline-3-
carbonitrile (6) (2.16 g, 10 mmol) and anhydrous sodium acetate
(1.23 g, 15 mmol) in ethanol (30 ml), the appropriate alkyl or
aralkylhalide (10 mmol) was added.The reaction mixture was
refluxed for 2 hours. On cooling, the resulting precipitate was
collected and recrystallized from ethanol in the form of white
needles.
2.4.1. 2-(Allylthio)-6-methoxyquinoline-3-carbonitrile (9a)
Yield (2.20 g, 86%); mp 115–116 °C; IR (KBr) υmax/cm−1; 3074 (CH
aromatic), 2988 (CH aliphatic) and 2215 (C≡N); 1H NMR (DMSO):
9.0 (s, 1H, quinoline H4), 7.9 (d, 1H, J = 9 Hz, quinoline H8), 7.5
(d, 1H, J = 9 Hz, quinoline H7), 7.4 (s, 1H, quinoline H5), 5.9 (m,
1H, CH alkene), 5.3 (d, 1H, J = 18 Hz, CH alkene), 5.1 (d, 1H,
J = 11 Hz, CH alkene), 4.0 (d, 2H, J = 7.2 Hz, S-CH2) and 3.9 (s, 3H,
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OCH3); MS (m/z, %); 256 (M, 61.25%), 241 (M – CH3, 100%) and
200 (M – CN, OCH3, 26.9%); Anal. Calcd for C14H12N2OS, (256):
C, 65.60; H, 4.72; N, 10.93; O, 6.24; S, 12.51%. Found: C, 65.83;
H, 4.81; N, 11.07%.
2.4.2. 6-Methoxy-2-(propylthio)quinoline-3-carbonitrile (9b)
Yield (1.93 g, 75%); mp 105–106 °C; IR (KBr) υmax/cm−1; 3080 (CH
aromatic), 2954 (CH aliphatic), 2220 (C≡N); 1H NMR (DMSO): 9.0
(s, 1H, quinoline H4), 7.9 (d, 1H, J = 9 Hz, quinoline H8), 7.5 (d,
1H, J = 9 Hz, quinoline H7), 7.4 (s, 1H, quinoline H5), 3.8 (s, 3H,
OCH3), 3.4 (t, 2H, J = 7.2 Hz, SCH2), 1.7 (m, 2H, CH2), 1.1 (t, 3H,
J = 16.2 Hz, CH3); MS (m/z, %); 258 (M, 14.42%), 243 (M – CH3, 5.4%),
229 (M – CH3CH2, 88%), and 83 (M –, 100%); Anal. Calcd for
C14H14N2OS, (258): C, 65.09; H, 5.46; N, 10.84%. Found: C, 65.21;
H, 5.53; N, 11.01%.
2.4.3. 2-(benzylthio)-6-methoxyquinoline-3-carbonitrile (9c)
Yield (2.60 g, 85%); mp 162–163 °C; IR (KBr) υmax/cm−1; 3042 (CH
aromatic), 2850 (CH aliphatic), 2218 (C≡N); 1H NMR (DMSO): 8.7
(s, 1H, quinoline H4), 7.9 (d, 1H, J = 9 Hz, quinoline H8), 7.6 (d,
1H, J = 9 Hz, quinoline H7), 7.5 (d, 2H, J = 6 Hz, phenyl H2, H6),
7.4 (s, 1H, quinoline H5), 7.3 (t, 2H, J = 6 Hz, phenyl H3, H5), 7.2
(t, 1H, phenyl H4), 4.6 (s, 2H, SCH2), 3.8 (s, 3H, OCH3).; MS (m/z,
%); 306 (M, 31.71%), 215 (M – C6H5CH2, 86%) and 91 (tropylium,
100%); Anal. Calcd for C18H14N2OS, (306): C, 70.56; H, 4.61; N, 9.14%.
Found: C, 70.73; H, 4.69; N, 9.31%.
2.4.4. 6-Methoxy-2-(phenethylthio)quinoline-3-carbonitrile
(9d)
Yield (2.72 g, 85%); mp 170–171 °C; IR (KBr) υmax/cm−1; 3080 (CH
aromatic), 2901 (CH aliphatic), 2222 (C≡N); 1H NMR (DMSO): 8.7
(s, 1H, quinoline H4), 7.9 (d, 1H, J = 9 Hz, quinoline H8), 7.6 (d,
1H, J = 9 Hz, quinoline H7), 7.5 (d, 2H, J = 6 Hz, phenyl H2, H6),
7.4 (s, 1H, quinoline H5), 7.3 (t, 2H, J = 6 Hz, phenyl H3, H5), 7.2
(m, 1H, phenyl H4), 3.9 (s, 3H, OCH3), 3.5 (t, 2H, J = 15.3 Hz, S-CH2),
3 (t, 2H, J = 15.3 Hz, CH2Ph); Anal. Calcd for C19H16N2OS, (320):
C, 71.22; H, 5.03; N, 8.74%. Found: C, 71.35; H, 5.18; N, 8.95%.
3. Results and discussion
3.1. Chemistry
New 6-methoxyquinoline-3-carbonitrile derivatives were pre-
pared through electrophilic substitution reaction of 2-mercapto-
6-methoxyquinoline-3-carbonitrile with chloroacetanilides, alkyl
chloroacetates and alkylhalides. The yield obtained by this
method was almost more than 75%. Structure elucidation of
amide derivatives 7a–f was performed based on their spec-
tral data (IR, 1H NMR, andMS).The IR spectra of these compound
showed the characteristic C=O absorption bands of amide at
the range of 1655–1674 cm−1 while the C≡N bands were ob-
served at the expected wavenumber in the range of 2220–
2225 cm−1. 1H NMR spectra of the amide derivatives 7a–f are
characterized by the presence of D2O exchangeable singlet of
the NH proton at the range of 10.1–10.4 in addition to another
singlet of three protons of methoxy group at 3.95 ppm. The
singlet of methylene CH2 bridge appears deshielded by the
action of both the adjacent Sulfur atom and carbonyl group.
Base peaks of the majority of these derivatives found almost
at m/z 257 by loss of NH-aryl fragments. Structures of ester
derivatives 8a–c were confirmed by IR, 1H NMR, and MS.There
were C=O bands characteristic of ester at the range of
1731–1735 cm−1 in addition to the C≡N bands. The 1H NMR
spectra showed singlet of the methoxy group three protons at
3.95 ppm as well as signals due to different alkyl groups at the
chemical shift of aliphatic region. Singlet of methylene CH2 ob-
served at 4.2–4.6 ppm. Furthermore, C≡N IR bands, OCH3 signals
were clearly detected in the spectra of all thioether deriva-
tives 9a–d. Compound 9c revealed its base beak at m/z 91 due
to tropylium carbocation. Detailed spectral data of all newly
synthesized compounds were given in the experimental section.
3.2. Results of antimicrobial testing
All of the newly synthesized derivatives were evaluated as an-
timicrobial against many Gram-positive and Gram-negative
bacteria as well as many fungal strains. The results of anti-
microbial evaluation showed promising activities for all of the
test compounds.The in vitro antibacterial activity of newly syn-
thesized derivatives was determined by disc diffusion method
on nutrient agar (Bauer et al., 1966). In this work, two Gram-
positive organisms (Streptococcus pneumoniae, Bacillus subtilis) and
two Gram-negative organisms (Pseudomonas aeruginosa, and Es-
cherichia coli) were used to investigate the antibacterial activity.
The tested compounds were screened for their antifungal ac-
tivity against Aspergillus fumigatus, Syncephalastrum racemosum,
Geotriucum candidum and Candida albicans by poisoned food tech-
nique (Thembo et al., 2010). Bacterial and fungal strains were
procured from the Regional Center for Micology and Biotech-
nology Laboratory, Cairo, Egypt. Ampicillin, Gentamicin and
Amphotricin B were used as standards for antibacterial and
antifungal studies respectively. The inhibition zones were re-
corded by visual observations after 24 h (bacteria) and 72–
96 h (fungi) of incubation. Results of antimicrobial studies and
the activity percent for each compound compared with the ref-
erence standard are presented in Tables 1, 2 and 3.
Screening procedure:The bacterial strain was uniformly spread
using sterilecotton swab on a sterile Petri dish MH agar. 1 mg/
mL for each test compounds were added to wells (7 mm
diameter holes cut in the agar gel, 20 mm apart from one
another). The systems were incubated for 24 h at 36 °C ± 1 °C,
under aerobic conditions. After incubation, confluent bacte-
rial growth was observed. Inhibition of the bacterial growth was
measured in mm and compared to that of reference
compounds.
4. Conclusion
From Tables 1, 2 and 3, it is clear that, the ester derivative 7b
and the thioether derivative 9c showed the highest antimi-
crobial activity against gram-positive strains while the highest
activity against gram-negative strains was observed in case of
7b, 7d and 9b. Compound 7e was found extremely potent
against three of the selected fungal strains. No activity was
found against C. albicans by any of the tested compounds. It
can be expected that such compounds may exert their bio-
logical effects by more than one mechanism.
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Table 1 – Results for antimicrobial activities of compounds 7a–f.
Comp. no. 7a 7b 7c 7d 7e 7f
Chemical structure
N
CNS
OCH3
NH
O
Cl
Cl
N
CNS
OCH3
NH
O
N
CNS
OCH3
NH
O
Cl
N
CNS
OCH3
NH
O
Cl
N
CNS
OCH3
NH
O
H3CO
N
CNS
OCH
NH
O
Br
Br
Br
I. Z. and % activity in Streptococcus pneumoniae 19.2 ± 0.55
80.6%
20.3 ± 0.37
85.29%
15.4 ± 0.19
64.71%
20.2 ± 0.19
84.87%
20 ± 0.43
84.03%
18.9 ± 0.44
79.41%
I. Z. and % activity in Bacillus subtilis 19.4 ± 0.52
59.88%
21.3 ± 0.25
65.74%
16 ± 0.58
49.38%
21.7 ± 0.24
66.9%
21.4 ± 0.53
66.04%
19.4 ± 0.53
59.88%
I. Z. and % activity in Pseudomonas aeruginosa NAa
0.0%
NA
0.00%
NA
0.0%
NA
0.00%
NA
0.0%
NA
0.00%
I. Z. and % activity in Escherichia coli 18.9 ± 0.58
88.73%
20.6 ± 0.37
96.71%
13.5 ± 0.44
63.38%
22.1 ± 0.24
103.76%
16.3 ± 0.33
76.53%
16.4 ± 0.23
77.0%
I. Z. and % activity in Aspergillus fumigatus 18.6 ± 0.36
78.48%
17.8 ± 0.36
75.11%
15.4 ± 0.44
64.98%
19.8 ± 0.44
83.54%
18.3 ± 0.34
77.22%
15.6 ± 0.53
65.82%
I. Z. and % activity in Syncephalastrum racemosum 17.3 ± 0.35
87.82%
18.3 ± 0.35
92.89%
14.6 ± 0.25
74.11%
18.7 ± 0.24
94.92%
21.1 ± 0.25
107.11%
12.7 ± 0.36
64.47%
I. Z. and % activity in Geotriucum candidum 16.5 ± 0.44
57.49%
14.9 ± 0.58
51.92%
13.1 ± 0.58
45.64%
17.3 ± 0.28
60.28%
21.3 ± 0.38
74.22%
16.3 ± 0.44
56.79%
I. Z. and % activity in Candida albicans NA
0.00%
NA
0.00%
NA
0.00%
NA
0.00%
NA
0.00%
NA
0.00%
I. Z. = Inhibition zone.
a No activity.
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Table 2 – Results for antimicrobial activities of compounds 8a–C.
Comp. no. 8a 8b 8c
Chemical structure
N
CN
S
OCH3
C2H5O O
N
CN
S
OCH3
H3CO O
N
CN
S
OCH3
C2H5O O
I. Z. and % activity in Streptococcus pneumoniae 10.6 ± 0.34
44.54%
15.9 ± 0.25
66.81%
17.7 ± 0.43
74.37%
I. Z. and % activity in Bacillus subtilis 13.7 ± 0.25
42.28%
17.1 ± 0.63
52.78%
19.3 ± 0.53
59.57%
I. Z. and % activity in Pseudomonas aeruginosa NA
0.00%
NA
0.00%
NA
0.00%
I. Z. and % activity in Escherichia coli 8.3 ± 0.58
38.97%
10.3 ± 0.44
48.36%
13.7 ± 0.25
64.32%
I. Z. and % activity in Aspergillus fumigatus 10.6 ± 0.25
44.73%
15.9 ± 0.25
67.09%
17.6 ± 0.58
74.26%
I. Z. and % activity in Syncephalastrum racemosum 11.1 ± 0.27
56.35%
16.1 ± 0.44
81.73%
19.4 ± 0.25
98.48%
I. Z. and % activity in Geotriucum candidum 11.9 ± 0.35
41.46%
19.2 ± 0.63
66.9%
19.9 ± 0.38
69.34%
I. Z. and % activity in Candida albicans NA
0.00%
NA
0.00%
NA
0.00%
Table 3 – Results for antimicrobial activities of compounds 9a–d.
Comp. no. 9a 9b 9c 9d
Chemical structure
N
NC S
H3CO
N
NC S
H3CO
N
NC S
H3CO
N
NC S
H3CO
I. Z. and % activity in Streptococcus pneumoniae 18.9 ± 0.44
79.41%
17.9 ± 0.37
75.21%
20.3 ± 0.43
85.29%
16.9 ± 0.44
71%
I. Z. and % activity in Bacillus subtilis 20.3 ± 0.58
62.65%
18.5 ± 0.28
57.1%
21.4 ± 0.53
66.05%
19.3 ± 0.25
59.57%
I. Z. and % activity in Pseudomonas aeruginosa NA
0.00%
NA
0.00%
NA
0.00%
NA
0.00%
I. Z. and % activity in Escherichia coli 18.9 ± 0.63
88.73%
19.1 ± 0.44
89.67%
16.9 ± 0.25
79.34%
14.9 ± 0.44
69.95%
I. Z. and % activity in Aspergillus fumigatus 16.3 ± 0.44
68.78%
15.7 ± 0.19
66.24%
17.6 ± 0.58
74.26%
15.6 ± 0.44
65.82%
I. Z. and % activity in Syncephalastrum racemosum 18.4 ± 0.58
93.4%
13.8 ± 0.19
70.05%
18.2 ± 0.25
92.39%
16.2 ± 0.58
82.23%
I. Z. and % activity in Geotriucum candidum 19.1 ± 0.37
66.55%
16.9 ± 0.37
58.89%
20.3 ± 0.38
70.73%
17.9 ± 0.37
62.37%
I. Z. and % activity in Candida albicans NA
0.00%
NA
0.00%
NA
0.00%
NA
0.00%
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